This site is intended for UK healthcare professionals only

Diabetes Professional Care
15-16 October 2024, Olympia London

The UK's leading event for the entire team involved in the prevention, treatment and management of diabetes and its related conditions.

Are you a UK healthcare professional?

We are unfortunately unable to allow patients to attend Diabetes Professional Care

If you would like more information on general practice or primary care, please refer to the NHS website.

Visit the NHS website

Legal Notice

DIABETES PROFESSIONAL CARE IS SUPPORTED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. SESSIONS DELIVERED WITH INPUT FROM OUR SUPPORTERS WILL ALWAYS BE MARKED ON THE PROGRAMME.
A FULL LIST OF CONFIRMED SUPPORTERS FOR DIABETES PROFESSIONAL CARE CAN BE FOUND HERE.
 

News

Subpage Hero

     

17 Oct 2022

Protein biomarkers help reveal people at risk of heart complications

Protein biomarkers help reveal people at risk of heart complications

Scientists have used protein biomarkers to help identify people with type 2 diabetes who are at high risk of cardiovascular outcomes and death.

The researchers studied the Biobank serum of nearly 5,000 people who took part in the ELIXA (Evaluation of Lixisenatide in Acute Coronary Syndrome) trial to assess the relationship between protein biomarkers and cardiovascular problems.

According to the findings, forward-selection Cox models identified independent protein risk factors for major adverse cardiovascular events (MACE) and death.

The researchers found that NT-proBNP and osteoprotegerin predicted both outcomes.

In addition, trefoil factor 3 predicted MACE, and angiopoietin-2 predicted death (C = 0.70 and 0.79, respectively, compared with 0.63 and 0.66 for clinical variables alone).

These proteins had all previously been identified and validated. Notably, C statistics for just NT-proBNP plus clinical risk factors were 0.69 and 0.78 for MACE and death, respectively.

The scientists concluded that NT-proBNP and other proteins independently predict cardiovascular outcomes in people with type 2 diabetes following acute coronary syndrome. Adding other biomarkers only marginally increased NT-proBNP’s prognostic value.

To access the full study, click here.

 

View all News
Loading

Sponsors

Diamond sponsor

 

Gold sponsor

Gold sponsor

Gold sponsor

Partners

Education Partner

Education Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Media Partner